Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations

Citation
I. Leviev et Rw. James, Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations, ART THROM V, 20(2), 2000, pp. 516-521
Citations number
28
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN journal
10795642 → ACNP
Volume
20
Issue
2
Year of publication
2000
Pages
516 - 521
Database
ISI
SICI code
1079-5642(200002)20:2<516:PPOHPP>2.0.ZU;2-N
Abstract
Paraoxonase (PON) is a serum enzyme with a wide species distribution. It pr otects lipoproteins from toxic oxidative modifications and is an antiathero genic mechanism of major potential. Activity levels of PON are major determ inants of the protective function; consequently, factors that influence PON levels ore of particular relevance. The present study has identified 3 pol ymorphisms in the promoter region of the human PON1 gene. Cell transfection studies have revealed their variable impact on promoter activity, with up to 2-fold differences in reporter gene expression. Genotyping studies have established that the polymorphisms are frequent in the population, a findin g that is consistent with a major impact on PON concentrations. The physiol ogical relevance of the polymorphisms was underlined by showing that they a re associated with highly significant differences in serum concentrations a nd activities of PON. The study thus firmly establishes a genetic basis for variations in serum PON levels and, consequently, serum PON activity. It i s consistent with the suggestion that variations in a major antioxidant fun ction of high density lipoprotein are, to an important degree, genetically determined.